-Minyanville

Other Tools: Calculators | My Watchlist | My Portfolio

DENDREON Add to My Watchlist

(NSDQ: DNDN)

Detailed Quote

Last Price	28.01 (11.20.09 5:20 PM EST)
Change (%)	-0.04 (-0.14%)
Volume	2,716,076
Open	28.56
Previous Close	28.05
Day's Range	28.68 - 27.80
Bid / Ask	28.01 / 28.03

Intraday

3 Month

6 Month

1 Year

Average Volume	3,022,290	Shares Outstanding	115.94M
52-Week Range	2.55 - 30.42	Market Cap	3.2B
P/E Ratio	-15.2	Earnings Per Share	-1.84
Dividend	N/A	Yield	N/A

Symbol	Last	Change (%)
RMD	50.25	+0.00 (+0.00)
WPI	35.15	+0.00 (+0.00)
HLUKF	18.90	+0.00 (+0.00)
NBHGF	29.70	+0.00 (+0.00)
0B52	44.84	+0.00 (+0.00)

Fri, Nov 06, 2009
	Buzz of the Street: Gold 1100? All day and every day some of the stock market's best and brightest traders and money managers share their ideas insights and analysis in real-time on Minyanville's Buzz & Banter. Check out some of the best of the buzz and for those minyans not currently subscribed click here for a free two-week trial. Note: Some links may require Buzz subscriptions.Monday November 2nd 2009Household CreationBy James AndersonOne of the things that has amused me during the Cash for Clunkers and the First Time Home Buyer tax credit programs is the unintended consequences of the programs. It doesn’t take a rocket scientist to see ... - Minyanville
Fri, Oct 30, 2009
	Trading Radar: Unemployment Expected to Climb As earnings season starts to wind down the health of the economy will be on everyone’s radar. This past week investors were greeted with a better than expected GDP number. It was the first time in four quarters we've seen positive GDP. Although the majority of the number came from government stimulus programs it was still good enough that economists started calling the recession over. Next week investors will be focused on an FOMC meeting and the jobs numbers. Analysts are expecting the unemployment rate to climb to 9.9% inching ever so close to the 10% level. With unemployment ... - Minyanville
Fri, Sep 25, 2009
	Buzz of the Street: Top Tick on FOMC Day? All day and every day some of the stock market's best and brightest traders and money managers share their ideas insights and analysis in real-time on Minyanville's Buzz & Banter. Check out some of the best of the buzz and for those minyans not currently subscribed click here for a free two-week trial. Note: Some links may require Buzz subscriptions.Monday September 21 2009Fibonacci Support LevlesBy David WaggonerIf there is anything left in this rally I am of the opinion that it can only extend from the last pivot at S&P 991.25. Therefore I am focusing on the shallow retracement levels of the ... - Minyanville
Wed, Sep 23, 2009
	Dendreon Picking Up Momentum for New Phase Dendreon (DNDN) has been one of the better-performing stocks in 2009 up over 500% on the strength of positive results from the IMPACT trial of Provenge for prostate cancer. As one of the longest-covering analysts on the company (just about 10 years now) I can say with some authority that Thursday’s Analyst Day marks a significant turning point for the company. Dendreon’s lead drug is Provenge an active immunotherapy for later-stage prostate cancer. The drug is highly likely to be approved by the FDA next year for use in men whose cancer has returned after prostate surgery where the ... - Minyanville
Wed, Jul 01, 2009
	Antigenics looks to foreign regulators before U.S. Scrappy biotech firm's stock has soared on hopes that it will finally be able to win regulatory approval for a kidney-cancer vaccine. - MarketWatch
More Featured Content

Fri, Nov 20, 2009
	Dendreon Receives FDA Acknowledgement of Complete Response - PR Newswire
Mon, Nov 16, 2009
	LiquidStockReport.com on Ground-Breaking Technology for a Greener Outlook - EmailWire.Com Press ...
Thu, Nov 12, 2009
	Unbiased Analysis on FITB, HCBK, ADSK, HBAN, FINL and DNDN Posted on WallStSense.com NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com - Marketwire
Wed, Nov 11, 2009
	Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization - PR Newswire
Thu, Nov 05, 2009
	WallstreetStockReview.com on Providing Advanced Solutions - MNDP - EmailWire.Com Press ...
More Press Releases

11/17/09		Special Conference Lazard Capital Markets 6th Annual Healthcare Conference Archive for DNDN
11/13/09		Special Conference Credit Suisse 2009 Healthcare Conference Archive for DNDN
11/11/09		Q3 2009 Earnings Archive for DNDN
11/10/09		Special Conference Merriman Investor Summit 2009 Archive for DNDN
09/24/09		Special Conference Dendreon Corporation Analyst Day Webcast Archive for DNDN

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs